Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice
about
Vascular Remodelling and Mesenchymal Transition in Systemic SclerosisMultifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis.Update on macrophages and innate immunity in sclerodermaGeniposide inhibited endothelial-mesenchymal transition via the mTOR signaling pathway in a bleomycin-induced scleroderma mouse model.Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features.Matrix remodeling in systemic sclerosis.Vasculopathy in scleroderma.Recent advances in animal models of systemic sclerosis.Epigenetic factors as drivers of fibrosis in systemic sclerosis.Serum heparanase levels: A protective marker against digital ulcers in patients with systemic sclerosis.Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma.A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis.Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study.The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway.A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.RGC32 Promotes Bleomycin-Induced Systemic Sclerosis in a Murine Disease Model by Modulating Classically Activated Macrophage Function.Blockade of TGF-β/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis.Fli1 deficiency and beyond: a unique pathway linking peripheral vasculopathy and dermal fibrosis in systemic sclerosis.A Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic SclerosisAn orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis
P2860
Q26749091-98921064-07E5-4A61-9597-3EA9D356BA55Q36371453-BDB31427-7776-4F6F-8B51-C63133979FB9Q36607887-D2D6E503-F36F-4717-A769-24871B90477CQ37732969-CDD2789A-A3DF-4E0E-9E61-B5C7DE61212CQ38489606-9DDF2184-3926-40A6-B51F-E3715AE9DB9FQ38542590-D0BA94ED-DFC3-45C1-A80C-1BCAAFDC0469Q38543688-0E3959E6-14D1-4DCF-BDC1-5805FC48376CQ38701983-CC36C4DE-FE03-4CF8-ABFC-F063C14C1FDCQ39200920-AA69B207-2629-4131-B179-416204D87A50Q40266289-477F9C23-69C6-48DC-8891-6E6AFEC9FBAEQ40316188-29CFAF52-E5B0-4806-B316-F4D9D75529B0Q40321155-8744E330-ADAB-44DE-9228-E3E724456097Q40368781-23177F70-08B0-4637-BC59-1283C04CF552Q41980258-C0C4C7DC-4047-40C9-9470-5D81FD90EDEFQ42369819-C2355D4A-3868-4C8C-94D3-3B85438E3A67Q47399059-FAC3EE63-CA3A-441E-B813-272E0BFF6DD9Q48177844-F2CDB549-1848-4AF9-9EC4-91B03433FF55Q49989946-6B308FF5-3851-4617-89CC-54911EBF5540Q52673265-594FCE98-9EE6-49EE-97B5-596E0C1802A8Q52726337-AFFF6BB6-B411-4E5F-8F8E-5B4A23A2878EQ53662594-5C0E6FBA-601D-471A-8455-866EA549ACEFQ57072741-5AC9558C-7537-47F5-AC8A-D62628EA0E7EQ58797878-FE5CBE98-032E-4B01-9A39-946C8425196D
P2860
Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Fibrosis, vascular activation, ...... d Fli-1-haploinsufficient mice
@ast
Fibrosis, vascular activation, ...... d Fli-1-haploinsufficient mice
@en
type
label
Fibrosis, vascular activation, ...... d Fli-1-haploinsufficient mice
@ast
Fibrosis, vascular activation, ...... d Fli-1-haploinsufficient mice
@en
prefLabel
Fibrosis, vascular activation, ...... d Fli-1-haploinsufficient mice
@ast
Fibrosis, vascular activation, ...... d Fli-1-haploinsufficient mice
@en
P2093
P2860
P356
P1476
Fibrosis, vascular activation, ...... d Fli-1-haploinsufficient mice
@en
P2093
Kaname Akamata
Maria Trojanowska
Shinichi Sato
Shinji Noda
Takashi Taniguchi
Takehiro Takahashi
Tetsuo Toyama
Yohei Ichimura
Yoshihide Asano
P2860
P304
P356
10.1002/ART.38948
P577
2015-02-01T00:00:00Z